Latest filing published 06 Oct 2014 for Asterias Biotherapeutics, Inc., €45k.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Scarsdale Equities LLC: trading record in brief
Scarsdale Equities LLC is a declared insider of Asterias Biotherapeutics, Inc., with filings sourced from SEC (Form 4). The record holds 6 filings, for trades running from 4 September 2014 to 1 October 2014.
Every open-market trade on record is a purchase: 6 purchases worth €721k, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
The median purchase comes to €90k.
The record was last updated on 6 October 2014 with an open-market purchase (€45k) in Asterias Biotherapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Scarsdale Equities LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,000 shares@ US$5.73Series A Common Stock, $0.0001 par valueSEC:0001532199-14-000008:0Canonical exit: 28 Dec 2014 (T+90)
- 50,000 shares@ US$5.97Series A Common Stock, $0.0001 par valueSEC:0001532199-14-000008:1Canonical exit: 30 Dec 2014 (T+90)
- 15,000 shares@ US$4.58Series A Common Stock, $0.0001 par valueSEC:0001532199-14-000007:0Canonical exit: 22 Dec 2014 (T+90)
- 10,000 shares@ US$5.35Series A Common Stock, $0.0001 par valueSEC:0001532199-14-000007:1Canonical exit: 23 Dec 2014 (T+90)
- 70,000 shares@ US$4.00Series A Common Stock, $0.0001 par valueSEC:0001532199-14-000006:0Canonical exit: 3 Dec 2014 (T+90)
- 30,000 shares@ US$5.48Series A Common Stock, $0.0001 par valueSEC:0001532199-14-000006:1Canonical exit: 4 Dec 2014 (T+90)
6 of 6 declarations